Mapping the interaction between high molecular mass kininogen and the urokinase plasminogen activator receptor

被引:36
|
作者
Mahdi, F
Shariat-Madar, Z
Kuo, A
Carinato, M
Cines, DB
Schmaier, AH
机构
[1] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA
[4] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
关键词
D O I
10.1074/jbc.M313850200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The urokinase plasminogen activator receptor (uPAR) is a multifunctional, GPI-linked receptor that modulates cell adhesion/migration and fibrinolysis. We mapped the interaction sites between soluble uPAR (suPAR) and high molecular mass kininogen (HK). Binding of biotin-HK to suPAR was inhibited by HK, 56HKa, and 46HKa with an IC50 of 60, 110, and 8 nM, respectively. We identified two suPAR-binding sites, a higher affinity site in the light chain of HK and 46HKa (His(477)-Gly(496)) and a lower affinity site within the heavy chain (Cys(333)-Lys(345)). HK predominantly bound to suPAR fragments containing domains 2 and 3 (S-D2D3). Binding of HK to domain 1 (S-D1) was also detected, and the addition of S-D1 to S-D2D3 completely inhibited biotin-HK or -46HKa binding to suPAR. Using sequential and overlapping 20-amino acid peptides prepared from suPAR, two regions for HK binding were identified. One on the carboxyl-terminal end of D2 (Leu(166)-Thr(195)) blocked HK binding to suPAR and to human umbilical vein endothelial cells (HUVEC). This site overlapped with the urokinase-binding region, and urokinase inhibited the binding of HK to suPAR. A second region on the amino-terminal portion of D3 (Gln(215)-Asn(255))also blocked HK binding to HUVEC. Peptides that blocked HK binding to uPAR also inhibited prekallikrein activation on HUVEC. Therefore, HK interacts with suPAR at several sites. HK binds to uPAR as part of its interaction with its multiprotein receptor complex on HUVEC, and the biological functions that depend upon this binding are modulated by urokinase.
引用
收藏
页码:16621 / 16628
页数:8
相关论文
共 50 条
  • [41] The urokinase plasminogen activator receptor-associated Protein/Endo180 is coexpressed with its interaction partners urokinase plasminogen activator receptor and matrix metalloprotease-13 during osteogenesis
    Engelholm, LH
    Nielsen, BS
    Netzel-Arnett, S
    Solberg, H
    Chen, XD
    Garcia, JML
    Lopez-Otin, C
    Young, MF
    Birkedal-Hansen, H
    Dano, K
    Lund, LR
    Behrendt, N
    Bugge, TH
    LABORATORY INVESTIGATION, 2001, 81 (10) : 1403 - 1414
  • [42] Characterization of the Interaction between Heterodimeric αvβ6 Integrin and Urokinase Plasminogen Activator Receptor (uPAR) Using Functional Proteomics
    Ahn, Seong Beom
    Mohamedali, Abidali
    Anand, Samyuktha
    Cheruku, Harish R.
    Birch, Debra
    Sowmya, Gopichandran
    Cantor, David
    Ranganathan, Shoba
    Inglis, David W.
    Frank, Ronald
    Agrez, Michael
    Nice, Edouard C.
    Baker, Mark S.
    JOURNAL OF PROTEOME RESEARCH, 2014, 13 (12) : 5956 - 5964
  • [43] Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor, and plasminogen activator inhibitor-1 and-2 in hepatocellular carcinoma
    Zhou, L
    Hayashi, Y
    Itoh, T
    Wang, WP
    Rui, JA
    Itoh, H
    PATHOLOGY INTERNATIONAL, 2000, 50 (05) : 392 - 397
  • [44] Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin
    Waltz, DA
    Natkin, LR
    Fujita, RM
    Wei, Y
    Chapman, HA
    JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (01): : 58 - 67
  • [45] INTERACTION OF UROKINASE-A CHAIN WITH THE RECEPTOR OF HUMAN KERATINOCYTES STIMULATES RELEASE OF UROKINASE-LIKE PLASMINOGEN-ACTIVATOR
    FIBBI, G
    MAGNELLI, L
    PUCCI, M
    DELROSSO, M
    EXPERIMENTAL CELL RESEARCH, 1990, 187 (01) : 33 - 38
  • [46] Urokinase-type plasminogen activator-induced monocyte adhesion is modulated by kininogen, kallikrein, factor XII, and plasminogen
    Li, CZ
    Gurewich, V
    Liu, JN
    EXPERIMENTAL CELL RESEARCH, 1996, 226 (02) : 239 - 242
  • [47] Ab initio molecular orbital calculations on specific interactions between urokinase-type plasminogen activator and its receptor
    Nagase, Keisuke
    Kobayashi, Hiroshi
    Yoshikawa, Eri
    Kurita, Noriyuki
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2009, 28 (01): : 46 - 53
  • [48] Hyperglycemia is associated with lower levels of urokinase-type plasminogen activator and urokinase-type plasminogen activator receptor in wound fluid
    Akinci, Bans
    Terzi, Cem
    Sevindik, Gokmen
    Yuksel, Faize
    Tunc, Ulku Aybuke
    Tunali, Sunay
    Yesil, Sena
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2014, 28 (06) : 844 - 849
  • [49] Urokinase plasminogen activator receptor: Prognostic biomarker for endometrial cancer
    Memarzedeh, S
    Kozak, KR
    Chang, L
    Natarajan, S
    Shintaku, P
    Reddy, ST
    Farias-Eisner, R
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (16) : 10647 - 10652
  • [50] The Urokinase Plasminogen Activator Receptor Promotes Efferocytosis of Apoptotic Cells
    D'mello, Veera
    Singh, Sukhwinder
    Wu, Yi
    Birge, Raymond B.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (25) : 17030 - 17038